Beaconcure Revenue and Competitors

Location

$21M

Total Funding

SaaS

Industry

Estimated Revenue & Valuation

  • Beaconcure's estimated annual revenue is currently $5.5M per year.(i)
  • Beaconcure's estimated revenue per employee is $121,600
  • Beaconcure's total funding is $21M.

Employee Data

  • Beaconcure has 45 Employees.(i)
  • Beaconcure grew their employee count by 7% last year.

Beaconcure's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
SVP CommercialReveal Email/Phone
3
Head Product DeliveryReveal Email/Phone
4
Director, Statistics and Life Sciences ConsultancyReveal Email/Phone
5
Director Design and UXReveal Email/Phone
6
Senior Project ManagerReveal Email/Phone
7
Sr. Manager, OperationsReveal Email/Phone
8
DevOps ManagerReveal Email/Phone
9
Senior Product ManagerReveal Email/Phone
10
Operations & Walfare ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.5M457%$20.7MN/A
#2
$0.7M180%N/AN/A
#3
$3.6M30-9%$24MN/A
Add Company

What Is Beaconcure?

With Beaconcure, pharmaceutical companies and CROs can validate clinical trial data for regulatory approval while cutting submission timelines in half!\n\nBy using 'Verify' by Beaconcure, any data inconsistency will be detected automatically during the QC process, reducing handling time and eliminating the possibility of an error-filled submission. \nIn collaboration with Pfizer, Beaconcure algorithms are designed and trained to support all types of therapeutic areas and study sizes. \nWith our technology, customers can introduce new treatments earlier to patients, while maintaining IP protection deadlines, accelerating the pipeline so that they can make early revenue and be first to market.\n#automation\n#machineLearning\n#AI\n#statisticalanalysis\n#regulatorysubmission\n#clinicaltrial

keywords:N/A

$21M

Total Funding

45

Number of Employees

$5.5M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.3M4513%N/A
#2
$5.2M457%$49M
#3
$4.7M457%N/A
#4
$5.2M45N/AN/A
#5
$8.4M45-4%N/A